This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McNaughton, S. A. Articles by Green, A. C. Search for Related Content PubMed PubMed Citation Articles by McNaughton, S. A. Articles by Green, A. C.

Role of Dietary Factors in the Development of Basal Cell Cancer and Squamous Cell Cancer of the Skin

¹ School of Population Health, University of Queensland and ² Queensland Institute of Medical Research, Herston, Queensland

Requests for reprints: Sarah McNaughton, Medical Research Council Human Nutrition Research, Elsie Widdowson Laboratory, Fulbourn Road, Cambridge CB1 9NL, United Kingdom. Phone: 44-1223-426356; Fax: 44-1223-437515. E-mail: sarah.mcnaughton{at}mrc-hnr.cam.ac.uk

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion Conclusions References

 
The role of dietary factors in the development of skin cancer has been investigated for many years; however, the results of epidemiologic studies have not been systematically reviewed. This article reviews human studies of basal cell cancer (BCC) and squamous cell cancer (SCC) and includes all studies identified in the published scientific literature investigating dietary exposure to fats, retinol, carotenoids, vitamin E, vitamin C, and selenium. A total of 26 studies were critically reviewed according to study design and quality of the epidemiologic evidence. Overall, the evidence suggests a positive relationship between fat intake and BCC and SCC, an inconsistent association for retinol, and little relation between ß-carotene and BCC or SCC development. There is insufficient evidence on which to make a judgment about an association of other carotenoids with skin cancer. The evidence for associations between vitamin E, vitamin C, and selenium and both BCC and SCC is weak. Many of the existing studies contain limitations, however, and further well-designed and implemented studies are required to clarify the role of diet in skin cancer. Additionally, the role of other dietary factors, such as flavonoids and other polyphenols, which have been implicated in skin cancer development in animal models, needs to be investigated.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion Conclusions References

 
Diet may play a substantial role in the development of many cancers and it has been estimated that 35% of all cancers are due to dietary factors (1). Although the influence of diet on the development of skin cancer is of considerable interest (2), the results of all salient epidemiologic studies have not been systematically reviewed.

Keratinocytic cancer is the most commonly occurring cancer among light-skinned populations and includes two types of cancer with distinct clinical, pathologic, and genetic features: basal cell cancer (BCC) and squamous cell cancer (SCC; refs. 3, 4). The key factor responsible for development of keratinocytic cancer is UV radiation (5). Other factors, including diet, may play an important role (2, 6) and dietary factors are hypothesized to act at many points in the multistage process of carcinogenesis (7, 8).

UV radiation induces skin cancer through the formation of DNA mutations or lesions induced by the absorption of UV photons and damage to various immune mechanisms (9-12). UV-induced free radicals can also damage cellular proteins and cell membrane carbohydrates and fatty acids, thus influencing the process of carcinogenesis through altered cellular communication (11), changes to cell receptor functioning (7), and alterations in DNA repair systems and cell proliferation pathways.

This review focuses on the role of fats, retinol, carotenoids, vitamin E, vitamin C, and selenium in the development of BCC and SCC and aims to evaluate the available epidemiologic evidence for these dietary factors. These particular dietary factors have been hypothesized to play a role in skin cancer development based on the results of animal and in vitro studies and have been the focus of epidemiologic research in humans (7, 8, 11, 13-22). Table 1 summarizes the potential mechanisms by which these dietary factors may act in the development and prevention of skin cancer. Although there are other nutrients that may potentially influence skin cancer development, such as folate and polyphenols, to date, few studies have examined their role.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion Conclusions References

The studies were reviewed according to their study design, including details of the case ascertainment and whether the diagnosis of BCC or SCC was based on self-report, clinical or histopathologic diagnosis, and aspects of the exposure measurement, such as the dietary assessment method and the timing of the biomarker measurement. Other considerations included selection of the study population, the number of skin cancer cases, and the management of potential confounding factors. A few studies did not distinguish between the two types of keratinocytic cancer; that is, they combined BCC and SCC in the analysis and this limitation has been highlighted as necessary.

The results of each study were considered in the context of a hierarchy of epidemiologic evidence. Case-control studies provide the weakest evidence of a relationship between an exposure and disease compared with other study designs and, in particular, hospital-based studies because of inherent selection bias compared with population-based designs. Methodologically sound cohort and nested case-control studies provide good evidence and sound intervention studies are considered to provide the best evidence (24).

	Results

Top Abstract Introduction Materials and Methods Results Discussion Conclusions References

 
A total of 26 studies investigating BCC and SCC risk in relation to the specific dietary factors of interest were identified in the literature, published between 1983 and 2004. This included six case-control studies (five hospital-based and one population-based), five cohort studies, seven nested case-control studies, and eight intervention studies as summarized in Tables 2, 3, 4, and 5 respectively. The findings for each dietary factor have been considered separately.

Overall, the studies suggest there may be a possible relationship between fat intake and keratinocytic cancer risk. One cohort study showed a significant positive association between long chain n – 3 fatty acids and BCC and an inverse relationship with total fat and monounsaturated fat (30), whereas the remaining two hospital-based case-control studies (26, 29) and one cohort study (28) showed no significant effects for BCC. There was no association found between dietary fat intake and SCC in the hospital-based case-control study by Hakim et al. (27).

There have been two intervention studies showing a reduction of keratinocytic cancer risk (BCC and SCC combined) with a reduction of fat intake (15, 25). These intervention studies provide stronger evidence than observational studies; however, as BCC and SCC were not investigated separately in these studies, it is unclear whether these effects would apply equally to each type of cancer. Of note, in the intervention study by Jaax et al. (15), the low fat intervention also resulted in increased intakes of ß-carotene, vitamin C, and fiber, which suggests an increase in fruit and vegetable consumption. This is important considering the evidence supporting a protective role for fruit and vegetable consumption and these nutrients in many types of cancer (8).

Although only one of the existing observational studies found a relationship between keratinocytic cancer and fat intakes, it is also important to consider that the level of fat intake applied in the intervention studies (20% of energy) would be considered very low in the general population (31). It is possible that the range of fat intakes among participants of the observational studies thus did not allow a corresponding effect to be identified and this may explain the contrasting results.

Retinol
There have been three case-control studies (all hospital-based), two cohort studies, four nested case-control studies, and two intervention studies that have investigated the relationship between retinol (or vitamin A) and BCC or SCC (26, 28, 30, 32-39).

The results of studies investigating the relationship between retinol and keratinocytic cancer have been inconsistent. For BCC, an inverse association was shown with use of vitamin A supplements in the hospital-based case-control study by Wei et al. (39). No relationship was shown between either plasma retinol concentrations or intake in two case-control studies, two nested case-control studies (33), two cohort studies (28, 30), and two intervention studies (36, 37). In contrast, Breslow et al. (32) found that serum retinol levels were higher among patients with BCC compared with controls.

With respect to SCC, two intervention studies provided contradictory results with the study by Moon et al. (37) showing a protective effect of retinol, whereas the study by Levine et al. (36) found no protective effect. Both studies used a similar dose of retinol and included subjects with a previous history of skin cancer. The remaining observational studies (one hospital-based case-control study and two nested case-control studies) found no relationship with SCC (26, 32, 34).

Additionally, in one case-control study and one nested case-control study in which BCC and SCC were not investigated separately, there was an inverse association between serum retinol and keratinocytic cancer risk (35, 38).

Carotenoids
There have been 15 studies investigating carotenoids and keratinocytic cancer, including 2 case-control studies (both hospital-based), 5 cohort studies, 5 nested case-control studies, and 3 intervention trials (28-30, 32-34, 40-45). The majority of these studies have investigated either serum/plasma levels or dietary intake of ß-carotene only. Intakes of carotenoids other than ß-carotene have been investigated in analyses of the Nurses' Health Study (46, 47) and in the cohort study by Dorgan et al. (45), and serum lycopene has been investigated in two nested case-control studies (32, 40).

There is little evidence for a protective effect of ß-carotene in BCC or SCC. None of the studies investigating intake or plasma ß-carotene concentrations found an association with BCC risk (one hospital-based case-control, three nested case-control, four cohort studies, and three intervention studies; refs. 28-30, 32, 34, 40-43, 45, 46). There have been fewer studies investigating ß-carotene and SCC risk; however, no relationship was found in the two nested case-control studies (32, 34), two cohort studies (45, 47), and one intervention study (42) when either plasma ß-carotene or intake was assessed. Only the hospital-based case-control study, which investigated BCC and SCC combined, found higher plasma ß-carotene and a higher intake of ß-carotene containing vegetables among controls compared with cases (35).

There is insufficient evidence to draw solid conclusions on the relationship between other carotenoids and BCC or SCC risk, as the evidence is limited to three cohort studies of -carotene, ß-cryptoxanthin, and lutein and/or zeaxanthin (46, 47) and two nested case-control studies of serum lycopene (32, 40). With respect to -carotene, no relationship between was found with either BCC (two cohort studies) or SCC (two cohort studies) using either serum or dietary intake measurements (45-47). For ß-cryptoxanthin and lutein and/or zeaxanthin, no relationship was identified in two cohort studies of BCC (45, 46), but for SCC the two cohort studies were inconsistent with one showing no effect (47), whereas a recent study using serum levels showed a positive relationship with SCC (45). Similarly, lycopene was found not to be associated with either BCC (one nested case-control study and one cohort study) or SCC (two nested case-control studies and one cohort study; refs. 32, 40, 45).

Vitamin E
There have been 12 studies investigating vitamin E and the risk of keratinocytic cancer (28-30, 32-34, 39, 40, 45-48). Five of the studies investigated serum levels of vitamin E, whereas six of the studies investigated dietary intake of vitamin E and one study investigated intake of vitamin E supplements.

The evidence for a protective effect of vitamin E in BCC or SCC is weak. For BCC risk, no relationship was found between plasma and intake in six studies (one case-control, three cohort, and two nested case-control; refs. 28-30, 32, 40, 45). An inverse relationship was found between intake and BCC risk in two studies (one hospital-based case-control and one nested case-control; refs. 33, 39); in contrast, one cohort study showed a significant positive relationship between vitamin E intake and BCC risk (46). The four studies that investigated SCC showed no relationship with vitamin E (two nested case-control studies and one cohort study; refs. 32, 34, 45, 47). Similarly, the nested case-control study by Wald et al. (48), which did not distinguish between BCC and SCC, also found no significant association between serum vitamin E and keratinocytic cancer risk.

Vitamin C
Three case-control studies (all hospital-based), four cohort studies, and one nested case-control study have investigated the dietary intake of vitamin C and one case-control study investigated the use of vitamin C supplements and risk of keratinocytic cancer (26, 28-30, 33, 35, 39).

With respect to vitamin C and BCC, the available evidence for a protective effect is weak. In analysis of the Nurses' Health Study cohort, Fung et al. (46) found a significant, but small, positive relationship between vitamin C intake and BCC, whereas the hospital-based case-control study by Wei et al. (39) showed an inverse association between BCC risk and use of vitamin C supplements. The four remaining studies (one hospital-based case-control study, two cohort studies, and one nested case-control study) found no relationship between vitamin C and BCC (28-30, 33).

There are fewer studies investigating vitamin C and SCC risk, with only one hospital-based case-control (26) and one cohort study (47); both found no relationship between vitamin C intake and SCC risk.

In addition, the hospital-based case-control study by Kune et al. (35) investigated BCC and SCC combined and found that a high intake of ß-carotene and vitamin C containing foods was significantly related to reduced risk of keratinocytic cancer.

Selenium
There have been two case-control studies (both hospital-based), three nested case-control studies, and one intervention trial investigating the relationship between selenium and keratinocytic cancer (29, 32-34, 49-51). Three of these studies investigated selenium exposure using serum/plasma measurements, whereas three studies investigated dietary intakes of selenium.

The evidence suggests that there is no protective effect of selenium in BCC or SCC. With respect to selenium and BCC, only one case-control study found an inverse relationship between plasma selenium and BCC (49), whereas no relationship with selenium intake or plasma concentrations was shown in the remaining studies (two case-control studies, two nested case-control studies, and one intervention study; ref. 50). Of the four studies investigating the relationship between selenium and SCC (one case-control study, two nested case-control studies, and one intervention study), none identified a significant relationship (32, 34, 49, 50).

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion Conclusions References

 
This review has focused on evaluating the possible role of fats, retinol, carotenoids, vitamin E, vitamin C, and selenium in the development of cutaneous BCC and SCC. A total of 26 studies were critically reviewed according to study design and quality of the epidemiologic evidence. Overall, there is a possible positive relationship between fat intake and BCC and SCC, but for the remaining dietary factors the evidence is, at best, weak.

The potential mechanisms through which diet may influence the development of skin cancer, as summarized in Table 1, are well supported by the results of animal studies. Overall, the existing epidemiologic studies reviewed here have not provided strong evidence to support the role of dietary factors in skin cancer development. Dietary factors may not be of sufficient importance in keratinocytic cancer risk at a population level for an effect to be detected, and the effect of UV radiation may overwhelm any effects of diet. However, an ability to detect as association may also be hampered by limitations in the existing epidemiologic studies in key areas, including dietary exposure assessment, inclusion of subjects with previous skin cancers, and case ascertainment.

A potential explanation for the lack of effect of many of the dietary factors is that the relevant period of dietary exposure was not measured (28, 50, 52). It is acknowledged that BCCs have a long induction period and that the origins of disease may occur early in life (53). Serum/plasma biomarkers used in many of the studies are hypothesized to represent dietary exposure over the short term, and although the dietary intake measurements used have tended to represent a longer-term measurement of habitual intake (54), the appropriate exposure period may not have been investigated. Therefore, it is still possible that dietary factors may act at earlier stages of keratinocytic cancer development.

However, it has been shown that some dietary factors may act in the late stages of carcinogenesis. Synthetic retinoids have rapid effects on BCC risk and probably act in the late stages of carcinogenesis (28). This suggests that different dietary factors may act at different stages of the carcinogenic process, and the relevant exposure period may be different according the dietary factor under consideration.

Similarly, with respect to many of the interventions trials, it has been suggested that the treatment period may have been too short (50, 52). In reference to the potential effects of selenium, Clark et al. suggested that although an effect of selenium supplementation on total cancer mortality and lung, colorectal, and prostate cancer incidence could be detected the treatment period for BCC and SCC may have been to short (50). It was suggested that UV radiation increases the risk of BCC and SCC through a genetic mutation preventing apoptosis, which occurs early in the process of skin carcinogenesis, whereas in other types of cancer this mutation occurs late in the process. They proposed that if the primary protective action of selenium is the stimulation of cell death, prevention of SCC and BCC may require a longer treatment period than other cancers; otherwise, a significant number of cells already contain the mutation and selenium treatment cannot reverse the effects (50). With respect to trials of ß-carotene supplementation, Manson et al. (52) also suggested that the treatment and follow-up periods of 5 years may have been too short. These authors also suggested that many of the skin cancers detected during the study period may have been present when the treatment began; therefore, ß-carotene would not have had an effect unless it acted late in carcinogenesis. However, later studies with longer treatment periods also showed no effect, suggesting that this was not the reason for a lack of effect of ß-carotene (41). An alternate explanation is that the cancer-protective action seen in observational dietary studies, which has been attributed to ß-carotene, may not actually be due to ß-carotene but due to some other dietary component that is closely associated with ß-carotene (40, 55, 56). This has been suggested in the prevention of lung cancer where a large number of observational studies have supported the role of ß-carotene, but large intervention trials have shown either no effect or an adverse effect (57).

This review included six case-control studies; however, case-control studies (and in particular, hospital-based case-control studies) provide the weakest evidence of a relationship between an exposure and disease compared with other study designs (24). Prospective study designs, such as nested case-control and cohort studies, avoid concerns over recall bias and clearly define the temporal relationship between exposure and onset of disease. This is particularly important when considering serum/plasma biomarkers as measures of dietary exposure (58). Contrasting results have been shown in studies using plasma biomarkers depending on the timing of the plasma biomarkers. In a case-control study of plasma selenium, there were significant inverse relations with BCC (49); however, in a study based on prospectively collected data, there was no association between keratinocytic cancer and selenium (32). Similar discrepancies were identified in the study by Wald et al. (38) in which mean serum retinol levels were significantly lower among cases compared with controls but only when patients with <1 year between collection of the blood sample and diagnosis of cancer were investigated. These results highlight the importance of using prospectively collected blood samples.

Many of the studies of BCC and SCC included participants that had had a previous BCC. These subjects are at a higher risk of subsequent skin cancers (59). It is unclear from the existing literature whether dietary factors act differently in the development of a first skin cancer or in subsequent skin cancers. The inclusion of participants with a previous history of skin cancer may only affect the findings if dietary factors act in the early stage of keratinocytic skin cancer. As described above, some dietary factors, such as retinol, have been shown to act in the later stages of carcinogenesis; however, early stage effects have not been completely dismissed.

A further limitation of several studies relates to the methods used for ascertaining cases of keratinocytic cancer. Firstly, several studies relied on health records and cancer registries, which increase the potential for misclassification with respect to skin cancer outcome (32, 33, 38, 40, 44, 48). Secondly, several studies only used self-report of keratinocytic cancer (28, 30, 46, 47). The validity of the self-report measures was assessed in analyses of the Nurses' Health Study and the Health Professionals' Follow-up Study (28, 30, 46), although in the former study it was conducted among a small number of subjects.

A few studies did not distinguish between the two types of keratinocytic cancer; that is, they combined BCC and SCC in the analysis (15, 25, 35, 38, 44, 48). Despite this, these studies were retained in the review as they included two intervention studies, which are considered to provide strong epidemiologic evidence. However, it is unclear whether the effects of diet would apply equally to each type of skin cancer and it is possible that combining the outcomes in the analysis may attenuate any effects of diet.

Another important limitation of the existing published literature is that in many of the earlier studies there is inadequate investigation and control for potential confounders (26). Many of the case-control studies match cases and controls for major factors, such as age and sex (29), but the potential confounding effects of other skin cancer risk factors are overlooked. This is important as there is clustering of healthy lifestyle behaviors (60, 61); for example, intakes of fruits and vegetables are higher in nonsmokers compared with smokers (62). These relationships may also exist between healthy eating behaviors and a variety of sun protection behaviors and other skin cancer risk factors.

	Conclusions

Top Abstract Introduction Materials and Methods Results Discussion Conclusions References

 
Overall, the studies suggest that there may be a possible positive relationship between fat intake and BCC and SCC, whereas the results for retinol are inconsistent with both positive and negative relationships with both BCC and SCC observed. There is little evidence for a role for ß-carotene in BCC or SCC development, whereas there is insufficient evidence on which to make a judgment for other carotenoids for either BCC or SCC. The evidence for associations between vitamin E, vitamin C, and selenium and BCC or SCC is weak.

Many of the studies of diet and keratinocytic cancer to date have limitations. The most common problems relate to limitations in the dietary exposure assessment, reliance on health records and cancer registries for cases ascertainment, combined analysis of BCC and SCC, small numbers of BCC or SCC cases, a lack of adjustment for potential confounding factors, and a lack of population-based studies. High-quality epidemiologic studies with adequate diagnosis of skin cancer, sufficient power, and adjustment for important confounding factors are required to clarify the role of many dietary factors in the development of skin cancer.

In addition, there remain several dietary factors that may have anticancer potential that have not been substantially investigated with respect to skin cancer, including flavonoids and other polyphenols, folate, vitamin D, Allium compounds, coumarins, riboflavin, and zinc (8). Further investigation into these dietary factors that may be involved in BCC and SCC development is required.

	Footnotes

 
Grant support: National Health and Medical Research Council Public Health Postgraduate Research Scholarship (S.A. McNaughton).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 1/12/05; revised 4/12/05; accepted 4/26/05.

	References

Top Abstract Introduction Materials and Methods Results Discussion Conclusions References

 

1. Working Group on Diet and Cancer. Nutritional aspects of the development of cancer: report of the Working Group on Diet and Cancer of the Committee on Medical Aspects of Food and Nutrition Policy. London: Department of Health (Great Britain); 1998.
2. Sies H, Stahl W. Nutritional protection against skin damage from sunlight. Annu Rev Nutr 2004;24:173–200.[CrossRef][Medline]
3. Leigh IM, Newton-Bishop JA, Kripke ML. Skin cancer. An introduction. Cancer Surv 1996;26:1–6.[Medline]
4. Green A, Battistutta D, Hart V, et al. The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants. Control Clin Trials 1994;15:512–22.[CrossRef][Medline]
5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Solar and ultraviolet radiation. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 55. Lyon: IARC; 1992.
6. Green A, Beardmore G, Hart V, et al. Skin cancer in a Queensland population. J Am Acad Dermatol 1988;19:1045–52.[Medline]
7. Flagg EW, Coates RJ, Greenberg RS. Epidemiologic studies of antioxidants and cancer in humans. J Am Coll Nutr 1995;14:419–27.[Abstract]
8. World Cancer Research Fund. Food, nutrition and the prevention of cancer: a global perspective. Washington: American Institute for Cancer Research; 1997.
9. Ullrich SE. Modulation of immunity by ultraviolet radiation key effects on antigen presentation. J Invest Dermatol 1995;105:30–6S.
10. Camplejohn RS. DNA damage and repair in melanoma and non-melanoma skin cancer. Cancer Surv 1996;26:193–206.[Medline]
11. Axelrod M, Serafin D, Klitzman B. Ultraviolet light and free radicals: an immunologic theory of epidermal carcinogenesis. Plast Reconstr Surg 1990;86:582–93.[Medline]
12. Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol 1997;133:1263–70.[Abstract]
13. Carroll KK. Dietary fat and cancer: specific action or caloric effect? J Nutr 1986;116:1130–2.
14. Greenwald P, Clifford CK, Milner JA. Diet and cancer prevention. Eur J Cancer 2001;37:948–65.
15. Jaax S, Scott LW, Wolf JE, Thornby JI, Black HS. General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutr Cancer 1997;27:150–6.[Medline]
16. Craven NM, Griffiths CE. Retinoids in the management of non-melanoma skin cancer and melanoma. Cancer Surv 1996;26:267–88.[Medline]
17. De Luca LM, Darwiche N, Celli G, et al. Vitamin A in epithelial differentiation and skin carcinogenesis. Nutr Rev 1994;52:S45–52.[Medline]
18. Fryer MJ. Evidence for the photoprotective effects of vitamin E. Photochem Photobiol 1993;58:304–12.[Medline]
19. Steinmetz KA, Potter JD. Vegetables, fruit and cancer. II. Mechanisms. Cancer Causes Control 1991;2:427–42.[CrossRef][Medline]
20. Black HS, Lenger WA, Gerguis J, Thornby JI. Relation of antioxidants and level of dietary lipid to epidermal lipid peroxidation and ultraviolet carcinogenesis. Cancer Res 1985;45:6254–9.[Medline]
21. Black HS, Mathews-Roth MM. Protective role of butylated hydroxytoluene and certain carotenoids in photocarcinogenesis. Photochem Photobiol 1991;53:707–16.[Medline]
22. Pence BC, Delver E, Dunn DM. Effects of dietary selenium on UVB-induced skin carcinogenesis and epidermal antioxidant status. J Invest Dermatol 1994;102:759–61.[CrossRef][Medline]
23. Medline. Bethesda: U.S. National Library of Medicine; 1966–2003.
24. Beaglehole R, Bonita R, Kjellstrom T. Basic epidemiology. Geneva: WHO; 1993.
25. Black HS, Thornby JI, Wolf JE, et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. Int J Cancer 1995;62:165–9.[Medline]
26. Graham S. Results of case-control studies of diet and cancer in Buffalo, New York. Cancer Res 1983;43:2409–13S.
27. Hakim IA, Harris RB, Ritenbaugh C. Fat intake and risk of squamous cell carcinoma of the skin. Nutr Cancer 2000;36:155–62.[CrossRef][Medline]
28. Hunter DJ, Colditz GA, Stampfer MJ, et al. Diet and risk of basal cell carcinoma of the skin in a prospective cohort of women. Ann Epidemiol 1992;2:231–9.[Medline]
29. Sahl WJ, Glore S, Garrison P, Oakleaf K, Johnson SD. Basal cell carcinoma and lifestyle characteristics. Int J Dermatol 1995;34:398–402.[Medline]
30. Van Dam RM, Huang Z, Giovannucci E, et al. Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr 2000;71:135–41.[Abstract/Free Full Text]
31. Mahan LK, Arlin S. Krause's food, nutrition, & diet therapy. Philadelphia: Saunders; 1992.
32. Breslow RA, Alberg AJ, Helzlsouer KJ, et al. Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, ß-carotene, lycopene, -tocopherol, and selenium. Cancer Epidemiol Biomarkers Prev 1995;4:837–42.[Abstract]
33. Davies TW, Treasure FP, Welch AA, Day NE. Diet and basal cell skin cancer: results from the EPIC-Norfolk cohort. Br J Dermatol 2002;146:1017–22.[CrossRef][Medline]
34. Karagas MR, Greenberg ER, Nierenberg D, et al. Risk of squamous cell carcinoma of the skin in relation to plasma selenium, -tocopherol, ß-carotene, and retinol: a nested case-control study. Cancer Epidemiol Biomarkers Prev 1997;6:25–9.[Abstract/Free Full Text]
35. Kune GA, Bannerman S, Field B, et al. Diet, alcohol, smoking, serum ß-carotene, and vitamin A in male nonmelanocytic skin cancer patients and controls. Nutr Cancer 1992;18:237–44.[Medline]
36. Levine N, Moon TE, Cartmel B, et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Cancer Epidemiol Biomarkers Prev 1997;6:957–61.[Abstract]
37. Moon TE, Levine N, Cartmel B, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Cancer Epidemiol Biomarkers Prev 1997;6:949–56.[Abstract]
38. Wald N, Boreham J, Bailey A. Serum retinol and subsequent risk of cancer. Br J Cancer 1986;54:957–61.[Medline]
39. Wei Q, Matanoski GM, Farmer ER, Strickland P, Grossman L. Vitamin supplementation and reduced risk of basal cell carcinoma. J Clin Epidemiol 1994;47:829–36.[Medline]
40. Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr 1991;53:260–4S.
41. Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH. A randomized, 12-year primary-prevention trial of ß carotene supplementation for nonmelanoma skin cancer in the Physician's Health Study. Arch Dermatol 2000;136:179–84.[Abstract/Free Full Text]
42. Green A, Wiiliams G, Neale R, et al. Daily sunscreen application and ß carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised trial. Lancet 1999;354:723–9.[CrossRef][Medline]
43. Greenberg ER, Baron JA, Stukel TA, et al. A clinical trial of ß carotene to prevent basal-cell and squamous-cell cancers of the skin. N Engl J Med 1990;323:789–95.[Abstract]
44. Wald NJ, Thompson SG, Densem JW, Boreham J, Bailey A. Serum ß-carotene and subsequent risk of cancer: results from the BUPA Study. Br J Cancer 1988;57:428–33.[Medline]
45. Dorgan JF, Boakye NA, Fears TR, et al. Serum carotenoids and -tocopherol and risk of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1276–82.[Abstract/Free Full Text]
46. Fung TT, Hunter DJ, Spiegelman D, et al. Vitamins and carotenoids intake and the risk of basal cell carcinoma of the skin in women (United States). Cancer Causes Control 2002;13:221–30.[Medline]
47. Fung TT, Spiegelman D, Egan KM, et al. Vitamin and carotenoid intake and risk of squamous cell carcinoma of the skin. Int J Cancer 2003;103:110–5.[Medline]
48. Wald NJ, Thompson SG, Densem JW, Boreham J, Bailey A. Serum vitamin E and subsequent risk of cancer. Br J Cancer 1987;56:69–72.[Medline]
49. Clark LC, Graham GF, Crounse RG, et al. Plasma selenium and skin neoplasms: a case-control study. Nutr Cancer 1984;6:13–21.[Medline]
50. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 1996;276:1957–63.[Abstract]
51. Duffield-Lillico AJ, Slate EH, Reid ME, et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 2003;95:1477–81.[Abstract/Free Full Text]
52. Manson JE, Hunter DJ, Buring JE, Hennekens CH. ß Carotene to prevent skin cancer. N Engl J Med 1991;324:923–5.[Medline]
53. Armstrong BK, Kricker A. Epidemiology of sun exposure and skin cancer. Cancer Surv 1996;26:133–53.[Medline]
54. Willett W, editor. Nutritional epidemiology. New York: Oxford University Press; 1998.
55. Tarasuk VS, Brooker AS. Interpreting epidemiologic studies of diet-disease relationships. J Nutr 1997;127:1847–52.[Abstract/Free Full Text]
56. Ziegler RG, Subar AF, Craft NE, et al. Does b-carotene explain why reduced cancer risk is associated with vegetable and fruit intake? Cancer Res 1992;52:2060–6S.
57. Albanes D. B carotene and lung cancer: a case study. Am J Clin Nutr 1999;69:1345–50S.
58. Rothman KJ, Greenland S. Modern epidemiology. Philadelphia: Lippincott-Raven; 1998.
59. Karagas MR, Stukel TA, Greenberg R, et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 1992;267:3305–10.[Abstract]
60. Pronk NP, Anderson LH, Crain AL, et al. Meeting recommendations for multiple healthy lifestyle factors. Am J Prev Med 2004;27:25–33.[CrossRef][Medline]
61. Schuit AJ, Van Loon AJ, Tijhuis M, Ocke M. Clustering of lifestyle risk factors in a general adult population. Prev Med 2002;35:219–24.[CrossRef][Medline]
62. Pollard J, Greenwood D, Kirk S, Cade J. Lifestyle factors affecting fruit and vegetable consumption in the UK Women's Cohort Study. Appetite 2001;37:71–9.[CrossRef][Medline]

This article has been cited by other articles:

				T. I Ibiebele, J. C van der Pols, M. C. Hughes, G. C Marks, G. M Williams, and A. C Green Dietary pattern in association with squamous cell carcinoma of the skin: a prospective study Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1401 - 1408. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McNaughton, S. A. Articles by Green, A. C. Search for Related Content PubMed PubMed Citation Articles by McNaughton, S. A. Articles by Green, A. C.